Parental segregation of autoimmunity in patients with Turner's syndrome: Preferential paternal transmission?

Journal of Autoimmunity

Volumn 12, Issue 1, 1999, Pages 65-72

  Larizza, Daniela ^a   Martinetti, Miryam ^b   Lorini, Renata ^a   Dugoujon, Jean Michel ^c   Tinelli, Carmine ^b   Vitali, Letizia ^a   Calcaterra, Valeria ^a   Cuccia, Mariaclara ^a   Severi, Francesca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c CHU PURPAN   (France)

Author keywords

Autoantibodies; GM; HLA; KM; Turner's syndrome

Indexed keywords

HLA DQ ANTIGEN; HLA DR7 ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; FEMALE; GENE FREQUENCY; HAPLOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TURNER SYNDROME;

EID: 0033081447     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0250     Document Type: Article

References (40)

1. Pai G.S., Leach D.C., Weiss L., Wolf C., Van Dyke D.L. 1977. Thyroid abnormalities in 20 children with Turner syndrome. J. Pediatr. 91: 267-269
2. Bright G.M., Blizzard R.M., Kaiser D.L., Clarke W.L. 1982. Organ-specific autoantibodies in children with common endocrine diseases. J. Pediatr. 100: 8-14
3. Germain E.L., Plotnick L.P. 1986. Age-related anti-thyroid antibodies and thyroid abnormalities in Turner syndrome. Acta Paediatr. Scand. 75: 750-755
4. Gruneiro de Papendieck L., Iorcansky S., Coco R., Rivarola MA., Bergadà C. 1987. High incidence of thyroid disturbances in 49 children with Turner syndrome. J. Pediatr. 111: 258-261
5. Lecornu M., Treussard I., Jezequel C. 1988. Thyroïdite et syndrome de Turner. Arch. Fr. Pediatr. 45: 411-412
6. Glück M., Attanasio A., Speer U., Butenandt O., Tietze H.U., Scherbaum W.A. 1992. Prevalence of autoantibodies to endocrine organs in girls with Ullrich-Turner syndrome aged 5-14 years. Horm. Res. 38: 114-119
7. De Kerdanet M., Lucas J., Lemee F., Lecornu M. 1994. Turner's syndrome with X-isochromosome and hashimoto's thyroiditis. Clin. Endocrinol. 41: 673-676
8. Vallotton M.B., Forbes A.P. 1967. Autoimmunity in gonadal dysgenesis and Klinefelter syndrome. Lancet 1: 648-651
9. Doniach D., Roitt I.M. 1968. Thyroid antibodies and sex chromosome anomalies. Proc. Roy. Soc. Med. 61: 278-280
10. Price W.H., Irvine W.J. 1969. Autoimmunity in women with sex chromosome aneuploidy and in their parents compared to controls. Clin. Exp. Immunol. 4: 365-374
11. Fialkow P.J., Uchida I.A. 1968. Autoantibodies in Down's syndrome and gonadal dysgenesis. Ann. NY Acad. Science 155: 759-769
12. Torf C.P., van den Berg B.J., Oechsli F.W., Christianson R.E. 1990. Thyroid antibodies as a risk factor for Down's syndrome and other trisomies. Am. J. Hum. Genet. 47: 727-734
13. Larizza D., Martinetti Bianchi M., Lorini R., Maghnie M., Dugoujon J.M., Cuccia Belvedere M., Severi F. 1989. Autoimmunity, HLA, Gm and Km polymorphisms in Turner's syndrome. Autoimmunity 4: 69-78
14. Larizza D., Zelaschi F., Vitali L., Lorini R. 1994. Autoantibodies in children and adolescents with Turner syndrome. Horm. Res. 41: 236
15. Dalton T.A., Bennet J.C. 1992. Autoimmune disease and the major histocompatibility complex: Therapeutic implications. Am. J. Med. 92: 183-188
16. Altmann D.M. 1992. HLA-DQ associations with autoimmune disease. Autoimmunity 14: 79-83
17. Nepom G.T., Erlich H. 1991. MHC class II molecules and autoimmunity Ann. Rev. Immunol. 9: 493-525
18. Van Loghem E. 1984. The immunoglobulin genes: Genetics, biological and clinical significance. Clin Immunol All. 4: 607-622
19. Nakao Y., Matsumoto H., Miyazaki T., Nishitani H., Takatsuki K., Kasukawa R., Nakayama S., Izumi S., Fujita T., Tsuji K. 1980. IgG heavy-chain allotypes (Gm) in autoimmune diseases. Clin. Exp. Immunol. 42: 20-26
20. Dougujon J.M., Cambon-Thomsen A. 1995. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: A review. Autoimmunity 22: 245-260
21. Martinetti M., Cuccia Belvedere M., Tafi A., Dugoujon J.M., Mazzacane D., Blanc M. 1988. Possible interaction between HLA and Ig light chain marker in susceptibility to uveitis. Dis. Markers 6: 257-262
22. Armitage P., Berry G. 1994. Statistical inference. In Statistical Methods in Medical Research. 3rd Edn, Blackwell Scientific Publications, Oxford, pp. 137-141
23. Winer B.J., Brown D.R., Michels K.M. 1991. Appendix E: Topics closely related to the analysis of variance. In Statistical Principles in Experimental Design. McGraw Hill, New York, pp. 1036-1039
24. Rothman K.J. 1986. Fundamentals of epidemiologic data analysis. In Modern Epidemiology. Boston, Little Brown and Co., pp. 147-150
25. Woolf B. 1955. On estimating the relation between blood groups and disease. Ann. Hum. Gen. 19: 251-253
26. Whittingham S., Mackay J.R., Mathews J.D. 1984. HlA-Gm interactions: Clinical implications. Clin Immunol All. 4: 623-639
27. Nienhuis H.E., Rongen-Westerlaken C., Geertzen H.G.M., Rijkers G.T., Zegers B.J.M., Wit J.M. 1993. Long-term effect of human growth hormone therapy on the prevalence of autoantibodies in Turner syndrome. Horm. Res. 39: (Suppl. 2): 49-53
28. Burek C.L., Hoffman W.H., Rose N.R. 1982. The presence of thyroid autoantibodies in children and adolescents with autoimmune thyroid disease and in their siblings and parents. Clin. Immunol. Immunopathol. 25: 395-404
29. Hall R., Dingle P.R., Roberts D.F. 1972. Thyroid antibodies: A study of first degree relatives. Clin. Genet. 3: 319-324
30. Mathur A., Stekol L., Schatz D., MacLaren N.K., Scott M.L., Lippe B. 1991. The parental origin of the single X chromosome in Turner syndrome: Lack of correlation with parental age or clinical phenotype. Am. J. Hum. Genet. 48: 682-686
31. Bias W.B., Reveille J.D., Beaty T.H., Meyers D.A., Arnett F.C. 1986. Evidence that autoimmunity in man is a Mendelian dominant trait. Am. J. Hum. Genet. 39: 584-602
32. Phillips D., McLachlan S., Stephenson A., Roberts D., Moffitt S., McDonald D., Ad'Hiah A., Stratton A., Young E., Clark F., Beever K., Bradbury J., Rees-Smith B. 1990. Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J. Clin. Endocrinol. Metab. 70: 742-746
33. Klimiuk P.S., Clague R.B., Grennan D.M., Dyer P.A., Smeaton I., Harris R. 1985. Autoimmunity to native type II collagen-a distinct genetic subset of rheumatoid arthritis. J. Rheumatol. 12: 865-870
34. Meddeb-Garnaoui A., Zeliszewski D., Mougenot J.F., Djilali-Saiah I., Caillat-Zucman S., Dormoy A., Gaudebout C., Tongio M.M., Baudon J.J., Sterkers G. 1995. Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French population. Hum. Immunol. 43: 190-199
35. Schmitt-Egenolf M., Eiermann T.H., Boehncke W-H., Ständer M., Sterry W. 1996. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DQA1*0201-DQB1*0303: A population- and family-based study. J. Invest. Dermatol. 106: 711-714
36. Martinetti M., Dugoujon J.M., Caforio A.L.P., Schwarz G., Gavazzi A., Graziano G., Arbustini E., Lorini R., McKenna W.J., Bottazzo G.F., Cuccia M. 1992. HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy Hum. Immunol. 35: 193-199
37. Matzuki K., Maeda H., Nomura Y., Segawa M. 1992. Distorsion of HLA gene transmission in childhood-onset myasthenia gravis. Lancet 340: 796
38. Vadheim C.M., Rotter J.L., Maclaren N.K., Riley W.J., Anderson C.E. 1986. Preferential transmission of diabetic alleles within the HLA gene complex. N. Engl. J. Med. 315: 1314-1318
39. Dacou-Voutetakis C., Georgopoulos N., Pappa H., Vlachos K., Tarassi K., Chryssovergi D., Papasteriades C.H.R. 1993. Increased frequency of HLA B17 antigen in girls with Turner syndrome and their fathers. Dis. Markers 11: 263-266
40. Dondi E., Gajdos P., Bach J.F., Garchon H-J. 1994. Association of Km allotype with increased serum levels of autoantibodies against muscle acetylcholine receptor in myasthenia gravis. J. Neuroimmunol. 51: 221-224